Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: Combined data of more than 15,000 patients from Pharmachild and national registries

J. Swart, G. Giancane, G. Horneff, B. Magnusson, M. Hofer, E. Alexeeva, V. Panaviene, B. Bader-Meunier, J. Anton, S. Nielsen, F. De Benedetti, S. Kamphuis, V. Staņěviča, M. Tracahana, L.M. Ailioaie, E. Tsitsami, A. Klein, K. Minden, I. Foeldvari, J.P. HaasJ. Klotsche, A.C. Horne, A. Consolaro, F. Bovis, F. Bagnasco, A. Pistorio, A. Martini, N. Wulffraat, N. Ruperto

Research output: Contribution to journalArticle

Cite this

Swart, J., Giancane, G., Horneff, G., Magnusson, B., Hofer, M., Alexeeva, E., Panaviene, V., Bader-Meunier, B., Anton, J., Nielsen, S., De Benedetti, F., Kamphuis, S., Staņěviča, V., Tracahana, M., Ailioaie, L. M., Tsitsami, E., Klein, A., Minden, K., Foeldvari, I., ... Ruperto, N. (2018). Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: Combined data of more than 15,000 patients from Pharmachild and national registries. Arthritis Research and Therapy, 20(1). https://doi.org/10.1186/s13075-018-1780-z